Lv11
58 积分 2025-10-25 加入
CYP4F11 promotes lung cancer progression through the miR-195/ME2 pathway
18分钟前
待确认
Consolidative nivolumab versus observation in unresectable stage III non-small cell lung cancer patients following neoadjuvant nivolumab plus chemotherapy and concurrent chemoradiotherapy (CA209-7AL): a randomized clinical trial
10个月前
已完结